Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis

Pierluigi Viale; Mario Furlanut; Francesco Cristini; Barbara Cadeo; Federica Pavan; Federico Pea

doi:10.1016/j.diagmicrobio.2006.11.010

Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis

Diagn Microbiol Infect Dis. 2007 May;58(1):137-9. doi: 10.1016/j.diagmicrobio.2006.11.010. Epub 2007 Mar 26.

Authors

Pierluigi Viale¹, Mario Furlanut, Francesco Cristini, Barbara Cadeo, Federica Pavan, Federico Pea

Affiliation

¹ Department of Medical and Morphological Research, Medical School, Clinic of Infectious Diseases, University of Udine, 33100 Udine, Italy. pierluigi.viale@uniud.it

PMID: 17368798
DOI: 10.1016/j.diagmicrobio.2006.11.010

Abstract

We report a case of acute bacterial meningitis due to Listeria monocytogenes whose successful treatment was mainly attributable to high-dose levofloxacin therapy (500 mg iv bid). This supports the hypothesis that levofloxacin may be an effective option for the treatment of listerial meningitis.

Publication types

Case Reports

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Cerebrospinal Fluid / microbiology
Female
Humans
Levofloxacin*
Listeria monocytogenes / drug effects*
Listeria monocytogenes / isolation & purification
Listeriosis / drug therapy
Listeriosis / microbiology
Meningitis, Listeria / drug therapy*
Meningitis, Listeria / microbiology
Ofloxacin / therapeutic use*
Treatment Outcome

Substances

Anti-Bacterial Agents
Levofloxacin
Ofloxacin